Pharmacogenomics Market: Information by Product and Services (Instruments, Services), Technology (NGS, PCR), Application (CVDs) and End User (Research), and Region — Forecast till 2029

Table Of Content

SECTION-1 MARKET STUDY OVERVIEW  

1          EXECUTIVE SUMMARY       

1.1       EXECUTIVE SUMMARY       

2          MARKET INTRODUCTION   

2.1       MARKET DEFINITION          

2.2       SCOPE OF THE STUDY         

2.3       MARKET STRUCTURE          

SECTION 2:   RESEARCH METHODOLOGY           

3          RESEARCH METHODOLOGY           

3.1       RESEARCH METHODOLOGY           

3.2       PRIMARY RESEARCH           

3.3       ASSUMPTIONS & EXCLUSIONS     

3.4       SECONDARY DATA SOURCES        

SECTION 3:    GLOBAL MARKET ANALYSIS          

4          MARKET FACTOR ANALYSIS          

4.1       PORTER’S FIVE FORCES ANALYSIS           

4.1.1   BARGAINING POWER OF SUPPLIERS       

4.1.2   BARGAINING POWER OF BUYERS            

4.1.3   THREAT OF SUBSTITUTION            

4.1.4   THREAT OF NEW ENTRANTS         

4.1.5   COMPETITIVE RIVALRY       

4.2       GLOBAL PGX MARKET: SWOT ANALYSIS

5          MARKET DYNAMICS            

5.1       DRIVERS         

5.1.1   CANCER—INSTRUMENTAL IN THE WIDESCALE UTILIZATION OF PHARMACOGENOMICS           

5.1.2   GROWING AWARENESS AND GOVERNMENT INITIATES DRIVE THE MARKET        

5.1.3   RESEARCH STUDIES AND PROVEN CLINICAL BENEFITS OF PHARMACOGENOMICS IGNITE THE MARKET GROWTH      

5.1.4   GROWING GERIATRIC POPULATION        

5.2       RESTRAINTS  

5.2.1   HIGH PRODUCT PRICES AND AVAILABILITY OF SERVICES HINDER THE MARKET GROWTH           

5.3       MARKET OPPORTUNITIES AND TRENDS 

SECTION 4:    ANALYSIS OF EXTERNAL FACTORS AFFECTION THE MARKET SCNARIO       

6          PARENT MARKET OVERVIEW        

6.1       PRECISION MEDICINE MARKET    

6.1.1   THE POTENTIAL OF PERSONALIZED MEDICINE 

6.2       GENOMICS MARKET: A STEPPING STONE FOR PGX SOLUTIONS       

6.2.1   MAJOR GENOMICS PROJECTS ACROSS THE GLOBE     

7          IMPACT OF COVID-19         

7.1       COVID-19: A GLOBAL PANDEMIC 

7.2       PHARMACOGENOMICS: HUMAN GENOME INTERACTIONS WITH REPURPOSED DRUGS           

7.3       PGX ANALYSIS: POST COVID-19   

SECTION 5:    SEGMENTAL ANALYSIS (TRENDS AND FORECAST)       

8          GLOBAL PHARMACOGENOMICS MARKET BY, PRODUCTS AND SERVICES  

8.1       INTRODUCTION       

8.1.1   MARKET SIZE AND FORECAST       

8.2       INSTRUMENTS          

8.2.1   MARKET SIZE & FORECAST            

8.3       CONSUMABLES        

8.3.1   MARKET SIZE & FORECAST            

8.4       SERVICES       

8.4.1   MARKET SIZE & FORECAST            

8.5       SOFTWARE    

8.5.1   MARKET SIZE & FORECAST            

9          GLOBAL PHARMACOGENOMICS MARKET BY, TECHNOLOGY 

9.1       INTRODUCTION       

9.1.1   MARKET SIZE AND FORECAST       

9.2       NEXT GENERATION SEQUENCING            

9.2.1   MARKET SIZE & FORECAST            

9.3       POLYMERASE CHAIN REACTION   

9.3.1   MARKET SIZE & FORECAST            

9.4       GEL ELECTROPHORESIS      

9.4.1   MARKET SIZE & FORECAST            

9.5       MASS SPECTROMETRY       

9.5.1   MARKET SIZE & FORECAST            

9.6       MICROARRAY           

9.6.1   MARKET SIZE & FORECAST            

9.7       HYBRIDIZATION       

9.7.1   MARKET SIZE & FORECAST            

9.8       OTHERS         

9.8.1   MARKET SIZE & FORECAST            

10        GLOBAL PHARMACOGENOMICS MARKET BY, APPLICATION  

10.1    INTRODUCTION       

10.1.1 MARKET SIZE AND FORECAST       

10.2    CARDIOVASCULAR DISEASE          

10.2.1 MARKET SIZE & FORECAST            

10.3    INFECTIOUS DISEASES        

10.3.1 MARKET SIZE & FORECAST            

10.4    ONCOLOGY   

10.4.1 MARKET SIZE & FORECAST            

10.5    NEUROLOGICAL DISEASES 

10.5.1 MARKET SIZE & FORECAST            

10.6    PSYCHIATRY  

10.6.1 MARKET SIZE & FORECAST            

10.7    PAIN MANAGEMENT AND TRAUMA       

10.7.1 MARKET SIZE & FORECAST            

10.8    OTHERS         

10.8.1 MARKET SIZE & FORECAST            

11        GLOBAL PHARMACOGENOMICS MARKET BY, END USERS     

11.1    INTRODUCTION       

11.1.1 MARKET SIZE AND FORECAST       

11.2    BIO-PHARMACEUTICAL COMPANIES       

11.2.1 MARKET SIZE & FORECAST            

11.3    RESEARCH AND ACADEMIC INSTITUTES 

11.3.1 MARKET SIZE & FORECAST            

11.4    CONTRACT RESEARCH ORGANIZATION AND MOLECULAR DIAGNOSTICS LABS    

11.4.1 MARKET SIZE & FORECAST            

11.5    OTHERS         

11.5.1 MARKET SIZE & FORECAST            

SECTION 6:    GLOBAL PHARMACOGENOMICS MARKET: TRENDS ANALYSIS AND FORECAST BY REGION          

12        GLOBAL PHARMACOGENOMICS MARKET TRENDS AND FUTURE OPPORTUNITY ANALYSIS BY REGION    

12.1    REGIONAL CLUSTER ANALYSIS: INTRODUCTION           

12.1.1 CLUSTER 1: THE U.S., CANADA, THE U.K., GERMANY  

12.1.2 CLUSTER 2: INDIA, JAPAN, FRANCE, CHINA, AUSTRALIA        

12.1.3 CLUSTER 3: SOUTH KOREA, THE MIDDLE EAST, SPAIN, ITALY           

12.1.4 CLUSTER 4: AFRICA 

13        GLOBAL PHARMACOGENOMICS MARKET BY, REGION           

13.1    INTRODUCTION       

13.1.1 MARKET SIZE & FORECAST            

13.2    AMERICAS     

13.2.1 MARKET SIZE & FORECAST            

13.2.1.1          BY PRODUCTS AND SERVICES       

13.2.1.2          BY TECHNOLOGY     

13.2.1.3          BY APPLICATION      

13.2.1.4          BY END USERS          

13.2.2 NORTH AMERICA     

13.2.2.1          MARKET SIZE & FORECAST            

13.2.2.1.1       BY PRODUCTS AND SERVICES       

13.2.2.1.2       BY TECHNOLOGY     

13.2.2.1.3       BY APPLICATION      

13.2.2.1.4       BY END USERS          

13.2.2.2          THE U.S.        

13.2.2.2.1       MARKET SIZE AND FORECAST       

13.2.2.2.1.1   BY PRODUCTS AND SERVICES       

13.2.2.2.1.2   BY TECHNOLOGY     

13.2.2.2.1.3   BY APPLICATION      

13.2.2.2.1.4   BY END USERS          

13.2.2.3          CANADA        

13.2.2.3.1       MARKET SIZE AND FORECAST       

13.2.2.3.1.1   BY PRODUCTS AND SERVICES       

13.2.2.3.1.2   BY TECHNOLOGY     

13.2.2.3.1.3   BY APPLICATION      

13.2.2.3.1.4   BY END USERS          

13.2.3 SOUTH AMERICA     

13.2.3.1          MARKET SIZE AND FORECAST       

13.2.3.1.1       BY PRODUCTS AND SERVICES       

13.2.3.1.2       BY TECHNOLOGY     

13.2.3.1.3       BY APPLICATION      

13.2.3.1.4       BY END USERS          

13.3    EUROPE         

13.3.1.1          BY PRODUCTS AND SERVICES       

13.3.1.2          BY TECHNOLOGY     

13.3.1.3          BY APPLICATION      

13.3.1.4          BY END USERS          

13.3.2 U.K.    

13.3.2.1          MARKET SIZE & FORECAST            

13.3.2.1.1       BY PRODUCTS AND SERVICES       

13.3.2.1.2       BY TECHNOLOGY     

13.3.2.1.3       BY APPLICATION      

13.3.2.1.4       BY END USERS          

13.3.3 GERMANY     

13.3.3.1          MARKET SIZE & FORECAST            

13.3.3.1.1       BY PRODUCTS AND SERVICES       

13.3.3.1.2       BY TECHNOLOGY     

13.3.3.1.3       BY APPLICATION      

13.3.3.1.4       BY END USERS          

13.3.4 FRANCE         

13.3.4.1          MARKET SIZE & FORECAST            

13.3.4.1.1       BY PRODUCTS AND SERVICES       

13.3.4.1.2       BY TECHNOLOGY     

13.3.4.1.3       BY APPLICATION      

13.3.4.1.4       BY END USERS          

13.3.5 SPAIN 

13.3.5.1          MARKET SIZE & FORECAST            

13.3.5.1.1       BY PRODUCTS AND SERVICES       

13.3.5.1.2       BY TECHNOLOGY     

13.3.5.1.3       BY APPLICATION      

13.3.5.1.4       BY END USERS          

13.3.6 ITALY  

13.3.6.1          MARKET SIZE & FORECAST            

13.3.6.1.1       BY PRODUCTS AND SERVICES       

13.3.6.1.2       BY TECHNOLOGY     

13.3.6.1.3       BY APPLICATION      

13.3.6.1.4       BY END USERS          

13.3.7 THE REST OF EUROPE (ROE)         

13.3.7.1          MARKET SIZE & FORECAST            

13.3.7.1.1       BY PRODUCTS AND SERVICES       

13.3.7.1.2       BY TECHNOLOGY     

13.3.7.1.3       BY APPLICATION      

13.3.7.1.4       BY END USERS          

13.4    ASIA PACIFIC

13.4.1 MARKET SIZE & FORECAST            

13.4.1.1          BY PRODUCTS AND SERVICES       

13.4.1.2          BY TECHNOLOGY     

13.4.1.3          BY APPLICATION      

13.4.1.4          BY END USERS          

13.4.2 CHINA

13.4.2.1          MARKET SIZE & FORECAST            

13.4.2.1.1       BY PRODUCTS AND SERVICES       

13.4.2.1.2       BY TECHNOLOGY     

13.4.2.1.3       BY APPLICATION      

13.4.2.1.4       BY END USERS          

13.4.3 JAPAN

13.4.3.1          MARKET SIZE & FORECAST            

13.4.3.1.1       BY PRODUCTS AND SERVICES       

13.4.3.1.2       BY TECHNOLOGY

13.4.3.1.3       BY APPLICATION      

13.4.3.1.4       BY END USERS          

13.4.4 INDIA 

13.4.4.1          MARKET SIZE & FORECAST            

13.4.4.1.1       BY PRODUCTS AND SERVICES       

13.4.4.1.2       BY TECHNOLOGY     

13.4.4.1.3       BY APPLICATION      

13.4.4.1.4       BY END USERS          

13.4.5 AUSTRALIA    

13.4.5.1          MARKET SIZE & FORECAST            

13.4.5.1.1       BY PRODUCTS AND SERVICES       

13.4.5.1.2       BY TECHNOLOGY     

13.4.5.1.3       BY APPLICATION      

13.4.5.1.4       BY END USERS          

13.4.6 SOUTH KOREA         

13.4.6.1          MARKET SIZE & FORECAST            

13.4.6.1.1       BY PRODUCTS AND SERVICES       

13.4.6.1.2       BY TECHNOLOGY     

13.4.6.1.3       BY APPLICATION      

13.4.6.1.4       BY END USERS          

13.4.7 THE REST OF ASIA PACIFIC (ROA)

13.4.7.1          MARKET SIZE & FORECAST            

13.4.7.1.1       BY PRODUCTS AND SERVICES       

13.4.7.1.2       BY TECHNOLOGY     

13.4.7.1.3       BY APPLICATION      

13.4.7.1.4       BY END USERS          

13.5    THE MIDDLE EAST & AFRICA (MEA)        

13.5.1 MARKET SIZE & FORECAST            

13.5.1.1          BY PRODUCTS AND SERVICES       

13.5.1.2          BY TECHNOLOGY     

13.5.1.3          BY APPLICATION      

13.5.1.4          BY END USERS          

13.5.2 MIDDLE EAST           

13.5.2.1          MARKET SIZE & FORECAST            

13.5.2.1.1       BY PRODUCTS AND SERVICES       

13.5.2.1.2       BY TECHNOLOGY     

13.5.2.1.3       BY APPLICATION      

13.5.2.1.4       BY END USERS          

13.5.3 AFRICA           

13.5.3.1          MARKET SIZE & FORECAST            

13.5.3.1.1       BY PRODUCTS AND SERVICES       

13.5.3.1.2       BY TECHNOLOGY     

13.5.3.1.3       BY APPLICATION      

13.5.3.1.4       BY END USERS          

SECTION 7:    COMPETITIVE ANALYSIS    

14        COMPETITIVE LANDSCAPE

14.1    INTRODUCTION       

14.2    MARKET SHARE ANALYSIS, 2020 

14.3    FINANCIAL COMPARISON OF FEW KEY MARKET PLAYERS     

14.4    LIST OF DIAGNOSTIC LABS AND PGX TESTING SERVICE PROVIDERS            

14.5    KEY DEVELOPMENTS & GROWTH STRATEGIES 

14.5.1 MERGER & ACQUISITION   

14.5.2 LAUNCH        

14.5.3 BUSINESS STRATEGY/EXPANSION            

SECTION 8:    COMPANY PROFILE 

15        COMPANY PROFILE 

15.1    THERMO FISHER SCIENTIFIC INC.

15.1.1 KEY FACTS     

15.1.2 OVERVIEW    

15.1.3 FINANCIAL DATA     

15.1.4 KEY PRODUCT CATEGORIES           

15.1.5 RECENT DEVELOPMENTS   

15.2    ADMERA HEALTH    

15.3    AGENA BIOSCIENCES, INC.            

15.4    ILLUMINA, INC.        

15.5    ONEOME, LLC          

15.6    MYRIAD GENETICS, INC.    

15.7    QUEST DIAGNOSTICS INCORPORATED   

15.8    DYNAMIC DNA LABORATORIES    

15.9    PERSONALIS INC.    

15.10  CORIELL LIFE SCIENCES      

15.11  PHAMATECH, INC   

15.12  BIOGENIQ INC.        

15.13  HAPLOPHARMA INC.          

15.14  VIENNALAB DIAGNOSTICS GMBH           

15.15  CENTOGENE N.V.    

Report Description Download Sample

Copyright . All rights Reserved By Straits Research